Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-059149

bluebird bio, Inc. · BLUE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jeffrey T. Walsh
Officer — Chief Financial · Other
Period of report
Nov 1, 2017
Accepted (ET)
Nov 3, 2017 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockNov 1, 2017M35,000$5.5004A62,305D
Common StockF2Nov 1, 2017S10,775$150.4576D51,530D
Common StockF3Nov 1, 2017S15,462$151.4518D36,068D
Common StockF4Nov 1, 2017S7,789$152.3022D28,279D
Common StockF5Nov 1, 2017S974$153.0958D27,305D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F6$5.5004Nov 1, 2017M35,000D—Jan 16, 2023Common Stock35,00027,585D

Explanation of responses